Form D · Other Health Care
Nova Mentis Life Science Corp.
Vancouver, A1 · CIK 0001689231
Offering snapshot reported Aug 4, 2020 · SEC filing
- Reported sold
- $12.2K Offering amount: $12.2K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 23, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 4, 2020 | Initial | $12,170 | No comparison | 1 | SEC filing |
| Feb 5, 2018 | Initial | $88,297 | No comparison | 6 | SEC filing |
| Nov 4, 2016 | Initial | $87,543 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-372464
U.S. dollar amounts are based on the Bank of Canada average rate of exchange reported on June 23, 2020, which was Cdn$1.3516=USD$1.00.
Source: Form D, filed Aug 4, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Keith Anderson | Director |
| Steven Feldman | Director |
| Doug Macdonell | Director |
| Dr. Aylia Mohammadi | Director |
| Kelly Pladson | Executive |
| William Rascan | Director, Executive |
| Jamie Robinson | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
700 838 West Hastings Street
Vancouver, A1, V6C 0A6
Vancouver, A1, V6C 0A6